Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal
混合纳米载体结合机制不同的药物，用于淋巴 CD4+ T 细胞活化和 HIV-1 潜伏期逆转
期刊:Science Advances
影响因子:11.7
doi:10.1126/sciadv.aav6322
Shijie Cao, Sarah D Slack, Claire N Levy, Sean M Hughes, Yonghou Jiang, Christopher Yogodzinski, Pavitra Roychoudhury, Keith R Jerome, Joshua T Schiffer, Florian Hladik, Kim A Woodrow
